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Autoimmunity has been proposed to play a role
in the pathogenesis of the nonspecific abdominal
aortic aneurysm (AAA).1-3 Histologic examination
of AAA specimens has also revealed Russell bodies,
which are hallmarks of autoimmunity, as in
Hashimoto’s thyroiditis.3
In the spectrum of autoimmune disorders certain
HLA alleles play a key role in the presentation of self
proteins as autoantigens in different specific condi-
tions.4 For example, among the vasculitic disorders,
giant cell arteritis appears to be related to the HLA-
DRB1*04 allele.5-6 In AAA two reports have sug-
gested the presence of specific susceptibility HLA-
DRB1 alleles. Tilson et al.7 found an association
with HLA-DR2 (*15 and *16), *12, and *13 in
North American black patients in a small study
group. Another study observed a high frequency of
HLA-DRB1*04 and *15 in inflammatory AAA.8
This study was undertaken to determine whether the
same susceptibility alleles appeared to be a factor in
a population of Japanese patients.
METHODS
Human subjects. Peripheral blood samples
were obtained from 46 consecutive patients with
AAA (who were competent to give consent). Blood
from volunteers was collected sequentially until the
target number of men and women gave consent to
participate in the study. The protocols for human
investigation were approved by the Institutional
Review Board at the Nagasaki University Hospital.
Patients. All subjects including the members of
the control group were Japanese and were referred
from the regional clinics surrounding the Nagasaki
University Hospital. The blood donors had no known
autoimmune diseases. Patients who had thoracoab-
dominal aneurysm, Marfan syndrome, mycotic
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aneurysm, Takayasu arteritis, Behcet disease, and
dissecting aneurysm were not included in this study.
Patients with a clinical diagnosis of inflammatory
aneurysm also were not included. Data for the fol-
lowing parameters were collected: age at diagnosis
of AAA, sex, size of aneurysm, type of presentation
(ruptured or nonruptured), and associated medical
problems.
HLA typing. HLA antigen typing was per-
formed in the Mitsubishi Biochemical Laboratory
(MBC, Tokyo, Japan). In brief, the basic protocol at
the MBC was to separate B cells from the peripher-
al blood with microbeads9 and then to determine by
the DR haplotypes lymphocyte inhibition tests with
rabbit anti-human HLA antigen antibodies.
Statistical analysis. The frequency of HLA-
DRB1 antigens of the patients were compared
with those of the members of the control group
with c 2 tests.
RESULTS
Demographic data. Forty-six patients with
AAA and 50 members of the control group were
studied. The AAA group consisted of 39 men and 7
women with an age distribution from 47 to 89 years
(mean, 71.6 years). The control group consisted of
41 men and 9 women with a slightly lower age dis-
tribution (41 to 85 years, mean, 67.3 years) than the
AAA group. Three AAAs were ruptured, and the
others were intact infrarenal AAAs with diameters
ranging from 4 cm to 10 cm with a mean of 5.79 ±
1.45 cm (±SD). No significant differences were
observed between the two groups in terms of asso-
ciated medical problems, as shown in Table I.
HLA typing. The results of HLA typing are
shown in Table II. The frequency of HLA DR2(15)
in the AAA group was significantly greater than in
the control group, with p < 0.005. No other differ-
ences reached statistical significance. Sex, age at diag-
nosis, size of aneurysm, and rupture status were com-
pared between the DR2(15) positive group and the
patients who were DR2(15)-negative. The results are
shown in Table III. No significant differences were
detected.
DISCUSSION
Autoimmune diseases are frequently associated
with certain HLA DR types. HLA-DRB1*0401 is
known to be important in the development of
rheumatoid arthritis.6 Weyand et al.5 have reported
that 98 (96%) of 102 patients express one of the
major North American disease-linked polymor-
phisms (*04, *0101, or *1402). Forty-seven
patients carried a double dose of the relevant
sequence. Nodular disease was expressed in 100% of
the patients with homozygous HLA-DR B1
*04/04. Thus patients with a double dose of a
major susceptibility allele tend to have more severe
manifestations of rheumatoid disease.
Although clinical differences in the HLA
DR2(15) positive and negative groups among the
patients with AAA did not reach statistical signifi-
cance, a tendency was observed that more female
patients with AAA were DR2(15) positive, and more
ruptured cases were also DR2(15) positive. Because
of perioperative mortality among the ruptured cases,
it was not possible to get consent from patients with
ruptured AAA. Accordingly, the true incidence of
the HLA DR2(15) positive rate among the patients
with ruptured AAAs is unknown.
The current findings are partially confirmatory of
the two HLA studies from North America. The two
previous studies and these results include HLA-
2(15) as a genetic risk factor for the AAA disease.7,8
The previous studies also suggested that additional
DR alleles may be important. Tilson et al.7 predict-
ed that in addition to DR2, 12, and 13, DR3 and 11
would also be susceptibility alleles based on their
amino acid sequences in the hypervariable region.
HLA-DR6 includes both DR13 and DR14 in this
study, but because of technical limitations they are
not differentiated here. If DR15, DR6, and DR12
are considered to be the high-risk serotypes in this
population, it is noteworthy that 78% of the patients
with AAA in this study had one of these types.
Table I. Demographic data of the screened
patients
AAA group Non-AAA group p Value
No. of cases 46 50
Male/female 39/7 41/9 NS
Age (yr) 71.6 ± 8.0 67.3 ± 10.2 0.025
Hypertension 39 34 NS
Coronary artery 13 17 NS
disease
Hyperlipidemia 14 9 NS
Peripheral artery 7 15 NS
disease
Diabetes 7 4 NS
Cerebrovascular 8 3 NS
accident
Chronic renal failure 4 1 NS
Malignancy 4 4 NS
Peptic ulcer disease 3 4 NS
Chronic obstructive 2 1 NS
pulmonary disease
NS, Not significant.
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Twelve patients with AAA and 6 patients in the con-
trol group were positive for a double dose of one of
these high-risk serotypes (p = 0.077). It is interest-
ing that two out of three cases of ruptured AAA had
double doses. 
The HLA typing was done in serologic fashion in
this study, not by DNA typing. HLA-DR2(15) fur-
ther classified DRB1*1501, 1502, 1503, and DR51
based on the DRB1 locus and DRB5 locus.10
Further studies will be necessary to differentiate
these genetic subtypes of the HLA-DR2(15) in
patients with AAA.
This study is limited to a regional Japanese pop-
ulation, so it is curious that the results are not incon-
sistent with the previous North American studies.
The frequencies of the haplotypes are similar
throughout the islands of Japan because of the sin-
gle race and geographically isolated region. It would
be interesting in the future to determine whether
the similar findings apply to Japanese living abroad,
for example, in Hawaii.
Screening for AAA by ultrasonography in the
HLA-DR2(15) positive population might focus
more accurately on one group of subjects who
would be most likely to benefit from early detection
and aneurysm repair.
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